The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Open accessAbstract
Cancer cells have metabolic dependencies that distinguish them from their normal counterparts. Among these dependencies is an increased use of the amino acid glutamine to fuel anabolic processes. Indeed, the spectrum of glutamine-dependent tumours and the mechanisms whereby glutamine supports cancer metabolism remain areas of active investigation. Here we report the identification of a non-canonical pathway of glutamine use in human pancreatic ductal adenocarcinoma (PDAC) cells that is required for tumour growth. Whereas most cells use glutamate dehydrogenase (GLUD1) to convert glutamine-derived glutamate into α-ketoglutarate in the mitochondria to fuel the tricarboxylic acid cycle, PDAC relies on a distinct pathway in which glutamine-derived aspartate is transported into the cytoplasm where it can be converted into oxaloacetate by aspartate transaminase (GOT1). Subsequently, this oxaloacetate is converted into malate and then pyruvate, ostensibly increasing the NADPH/NADP(+) ratio which can potentially maintain the cellular redox state. Importantly, PDAC cells are strongly dependent on this series of reactions, as glutamine deprivation or genetic inhibition of any enzyme in this pathway leads to an increase in reactive oxygen species and a reduction in reduced glutathione. Moreover, knockdown of any component enzyme in this series of reactions also results in a pronounced suppression of PDAC growth in vitro and in vivo. Furthermore, we establish that the reprogramming of glutamine metabolism is mediated by oncogenic KRAS, the signature genetic alteration in PDAC, through the transcriptional upregulation and repression of key metabolic enzymes in this pathway. The essentiality of this pathway in PDAC and the fact that it is dispensable in normal cells may provide novel therapeutic approaches to treat these refractory tumours.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, depending on the tissue of origin, cancer cells use various routes of glutamine metabolism. Some have been shown to require an exogenous glutamine supply for malignant proliferation [71,72], whereas others do not [73] and can synthesize it de novo [74].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [73]
In the citing paper
“For instance, KRAS-dependent upregulation of Glutamate Oxaloacetate Transaminase 1,2. (GOT) expression in pancreatic cancer facilitates production of aspartate for nucleotide biosynthesis, and allows NADPH generation via ME157,58 (Fig 2).”
From The metabolic landscape of RAS-driven cancers from biology to therapy (2021) · cites this paper as [57]
In the citing paper
“Mouse PDAC tumors driven by mutant Kras also experience metabolic alteration and are dependent on glucose and glutamine (73, 77).”
From KRAS mutation in pancreatic cancer (2021) · cites this paper as [77]
In the citing paper
“combining inhibition of glycolysis with blockade of KRAS effector signaling pathways has shown efficacy in culture and xenograft models197”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [197]
In the citing paper
“metabolic inhibition approaches combined with RAS pathway inhibitors have shown strong pre-clinical data and are currently in clinical trials197,224,225”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [197]
In the citing paper
“However, under normal and glucose-replete conditions, transamination is the dominant reaction that drives glutamine anaplerosis in cultured cells (79, 80, 81, 82).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Self-citationSpencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Hidalgo, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901557 · Cited by 2,570
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., et al. (2011) · Nature · doi:10.1038/nature10189 · Cited by 2,277
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Self-citationWise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Glutamine addiction: a new therapeutic target in cancer
Wise, D. R., & Thompson, C. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.003 · Cited by 1,770
Cited by
Sorted by citations
Items 801–900 of 1,004
The biological role of metabolic reprogramming in pancreatic cancer
Suzuki, T., Otsuka, M., Seimiya, T., Iwata, T., Kishikawa, T., & Koike, K. (2020) · MedComm · doi:10.1002/mco2.37 · Cited by 38
Andersen, H. B., Ialchina, R., Pedersen, S. F., & Czaplińska, D. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10004-4 · Cited by 40
Metabolomics specificity of tuberculosis plasma revealed by 1H NMR spectroscopy
Zhou, A., Ni, J., Xu, Z., Wang, Y., Zhang, H. S., Wu, W., Lu, S., Karakousis, P. C., & Yao, Y.-F. (2015) · Tuberculosis · doi:10.1016/j.tube.2015.02.038 · Cited by 38
Xue, M., Wei, W., Su, Y., Johnson, D., & Heath, J. R. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b12187 · Cited by 37
Ovarian cancer therapeutic potential of glutamine depletion based on GS expression
Furusawa, A., Miyamoto, M., Takano, M., Tsuda, H., Song, Y. S., Aoki, D., Miyasaka, N., Inazawa, J., & Inoue, J. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy033 · Cited by 38
Ferino, A., Miglietta, G., Picco, R., Vogel, S., Wengel, J., & Xodo, L. E. (2018) · RNA Biology · doi:10.1080/15476286.2018.1526536 · Cited by 38
Ningchuan, S., Liang, Y., Chen, Y., Wang, L., Li, D., Liang, Z., Sun, L., Wang, Y., & Niu, H. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4385 · Cited by 38
High Phosphoglycerate Dehydrogenase Expression Induces Stemness and Aggressiveness in Thyroid Cancer
Jeon, M. J., You, M., Han, J. M., Sim, S., Yoo, H. J., Lee, W. K., Kim, T. Y., Song, D. E., Shong, Y. K., Kim, W. G., et al. (2020) · Thyroid · doi:10.1089/thy.2020.0105 · Cited by 37
The role of glutamate oxaloacetate transaminases in sulfite biosynthesis and H2S metabolism
Mellis, A., Misko, A. L., Arjune, S., Liang, Y., Erdélyi, K., Ditrói, T., Kaczmarek, A. T., Nagy, P., & Schwarz, G. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101800 · Cited by 38
Molecular and Metabolic Subtypes Correspondence for Pancreatic Ductal Adenocarcinoma Classification
Espiau-Romera, P., Courtois, S., Parejo-Alonso, B., & Sancho, P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9124128 · Cited by 43
Cancer metabolism and dietary interventions
Qian, L., Zhang, F., Yin, M., & Lei, Q. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2021.0461 · Cited by 40
Holt, M. C., Assar, Z., Zavareh, R. B., Lin, L., Anglin, J. L., Mashadova, O., Haldar, S. D., Mullarky, E., Kremer, D. M., Cantley, L. C., et al. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00914 · Cited by 38
Self-citationMeng, G., Mao, X., Xu, C., Yuan, D., Schnurr, M. M., & Wei, J. (2013) · International Journal of Cancer · doi:10.1002/ijc.28416 · Cited by 38
Zhang, M., Fan, H., & Li, S. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.05.019 · Cited by 38
Targeting molecular addictions in cancer
Vivanco, I. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.461 · Cited by 41
Targeting Energy Metabolism in Cancer Treatment
Kubik, J., Humeniuk, E., Adamczuk, G., Madej, B., & Korga-Plewko, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105572 · Cited by 39
Emerging Therapies in CLL in the Era of Precision Medicine
Iyer, P. S., & Wang, L. (2023) · Cancers · doi:10.3390/cancers15051583 · Cited by 36
Wang, Q., Liu, J., Chen, Z., Zheng, J., Wang, Y., & Dong, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116021 · Cited by 44
Ferroptosis in cancer: metabolism, mechanisms and therapeutic prospects
Wu, Y., Li, H., Yue, K., Jing, C., & Duan, Y. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02520-6 · Cited by 44
Circulating Metabolites and Survival Among Patients With Pancreatic Cancer
Yuan, C., Clish, C. B., Wu, C. H., Mayers, J. R., Kraft, P. L., Townsend, M. K., Zhang, M., Tworoger, S. S., Bao, Y., Qian, Z. R., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv409 · Cited by 37
Self-citationJeong, S. M., Hwang, S., Park, K., Yang, S., & Seong, R. H. (2016) · Scientific Reports · doi:10.1038/srep30767 · Cited by 40
Chen, J., Chen, Y., Vail, G., Chow, H., Zhang, Y., Louie, L., Li, J., Hart, R. P., Plummer, M. R., & Herrup, K. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0127-y · Cited by 37
Mutant p53R270H drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma
Schofield, H. K., Zeller, J., Espinoza, C. E., Halbrook, C. J., Vecchio, A. D., Magnuson, B., Fabo, T., Daylan, A. E. C., Kovalenko, I., Lee, H., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.97422 · Cited by 38
Self-citationApproaches to inhibiting oncogenic K-Ras
Gorfe, A. A., & Cho, K. (2019) · Small GTPases · doi:10.1080/21541248.2019.1655883 · Cited by 36
Zhu, W., Radadiya, A., Bisson, C., Wenzel, S., Nordin, B. E., Martínez-Márquez, F., Imasaki, T., Sedelnikova, S. E., Coricello, A., Baumann, P., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0587-z · Cited by 37
Prełowska, M. K., Mehlich, D., Ugurlu, M. T., Kędzierska, H., Cwiek, A., Kośnik, A., Kaminska, K., Marusiak, A. A., & Nowis, D. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.02.020 · Cited by 37
Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells
Gebregiworgis, T., Purohit, V., Shukla, S. K., Tadros, S., Chaika, N. V., Abrego, J., Mulder, S. E., Gunda, V., Singh, P. K., & Powers, R. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00246 · Cited by 39
Targets (Metabolic Mediators) of Therapeutic Importance in Pancreatic Ductal Adenocarcinoma
Rai, V., & Agrawal, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228502 · Cited by 36
Liang, P., Li, Z., Chen, Z., Chen, Z., Jin, T., He, F., Chen, X., Gou, H., & Yang, K. (2025) · The FASEB Journal · doi:10.1096/fj.202403019r · Cited by 42
Joshi, S., Liu, M., & Turner, N. A. (2015) · BioMed Research International · doi:10.1155/2015/390863 · Cited by 36
Cancer metabolism and mass spectrometry-based proteomics
Zhou, W., Liotta, L. A., & Petricoin, E. F. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.11.003 · Cited by 38
Replication of the Shrimp Virus WSSV Depends on Glutamate-Driven Anaplerosis
Li, C.-Y., Wang, Y.-J., Huang, S.-W., Cheng, C.-S., & Wang, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146902 · Cited by 37
Román, M., López, I., Guruceaga, E., Baraibar, I., Ecay, M., Collantes, M., Nadal, E., Vallejo, A., Cadenas, S., Miguel, M. E.-D., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1479 · Cited by 36
Hara, Y., Minami, Y., Yoshimoto, S., Hayashi, N., Yamasaki, A., Ueda, S., Masuko, K., & Masuko, T. (2019) · Cancer Medicine · doi:10.1002/cam4.2689 · Cited by 38
Essential Role of Nonessential Amino Acid Glutamine in Atherosclerotic Cardiovascular Disease
Chen, J., Zhang, S., Wu, J., Wu, S., Xu, G., & Wei, D. (2019) · DNA and Cell Biology · doi:10.1089/dna.2019.5034 · Cited by 37
Amino Acid Oncometabolism and Immunomodulation of the Tumor Microenvironment in Lung Cancer
Fahrmann, J. F., Vykoukal, J. V., & Ostrin, E. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00276 · Cited by 35
Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy
Coleman, M. F., Cozzo, A. J., Pfeil, A. J., Etigunta, S. K., & Hursting, S. D. (2020) · Cancers · doi:10.3390/cancers12040852 · Cited by 37
Moore, A. M., Zhou, L., Cui, J., Li, L., Wu, N., Yu, A. C., Poddar, S., Liang, K., Abt, E. R., Kim, S., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012469118 · Cited by 39
Targeting RAS mutants in malignancies: successes, failures, and reasons for hope
Yang, H. S., Zhou, X., Fu, D., Le, C., Wang, J., Zhou, Q., Liu, X., Yuan, Y., Ding, K., & Xiao, Q. (2022) · 癌症：英文版 · doi:10.1002/cac2.12377 · Cited by 38
Pentose conversions support the tumorigenesis of pancreatic cancer distant metastases
Bechard, M. E., Word, A. E., Tran, A. V., Liu, X., Locasale, J. W., & McDonald, O. G. (2018) · Oncogene · doi:10.1038/s41388-018-0346-5 · Cited by 35
Metabolic Reprogramming: A Friend or Foe to Cancer Therapy?
McCann, C. K., & Kerr, E. M. (2021) · Cancers · doi:10.3390/cancers13133351 · Cited by 36
Yang, Y., He, P., Hou, Y., Liu, Z., Zhang, X., & Li, N. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154075 · Cited by 35
Glutamine metabolism, a double agent combating or fuelling hepatocellular carcinoma
Ziki, R. A., & Colnot, S. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101077 · Cited by 36
Liu, M., Hancock, S. E., Sultani, G., Wilkins, B. P., Ding, E., Osborne, B., Quek, L., & Turner, N. A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060822 · Cited by 35
The Many Facets of Tumor Heterogeneity: Is Metabolism Lagging Behind?
Loponte, S., Lovisa, S., Deem, A. K., Carugo, A., & Viale, A. (2019) · Cancers · doi:10.3390/cancers11101574 · Cited by 36
TFEB Supports Pancreatic Cancer Growth through the Transcriptional Regulation of Glutaminase
Kim, J. H., Lee, J., Cho, Y.-R., Lee, S., Sung, G., Shin, D., Choi, K., & Son, J. (2021) · Cancers · doi:10.3390/cancers13030483 · Cited by 38
Self-citationTuerhong, A., Xu, J., Shi, S., Tan, Z., Meng, Q., Hua, J., Liu, J., Zhang, B., Wang, W., Yu, X., et al. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03866-y · Cited by 35
Critical role of oncogenic KRAS in pancreatic cancer (Review)
Liu, J., Ji, S., Liang, C., Qin, Y., Jin, K., Liang, D., Xu, W., Shi, S., Zhang, B., Liu, L., et al. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5196 · Cited by 36
Metabolic Remodeling as a Way of Adapting to Tumor Microenvironment (TME), a Job of Several Holders
Serpa, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_1 · Cited by 35
p53-driven lipidome influences non-cell-autonomous lysophospholipids in pancreatic cancer
Butera, A., Roy, M. K., Zampieri, C., Mammarella, E., Panatta, E., Melino, G., D’Alessandro, A., & Amelio, I. (2022) · Biology Direct · doi:10.1186/s13062-022-00319-9 · Cited by 34
Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma
Shen, X., Niu, N., & Xue, J. (2022) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2022-0022 · Cited by 39
Targeting ALDH1A1 to enhance the efficacy of KRAS-targeted therapy through ferroptosis
Bian, Y., Shan, G., Bi, G., Liang, J., Hu, Z., Sui, Q., Shi, H., Zheng, Z., Yao, G., Wang, Q., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103361 · Cited by 34
Targeting metabolic reprogramming as a potential therapeutic strategy in melanoma
Smith, L. K., Rao, A. D., & McArthur, G. A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.02.009 · Cited by 36
Linden, C. V., & Corbet, C. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.016 · Cited by 34
Intracellular nanoparticle delivery by oncogenic KRAS-mediated macropinocytosis
Liu, X., & Ghosh, D. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s212861 · Cited by 35
Metabolism remodeling in pancreatic ductal adenocarcinoma
Li, J., Wang, Y.-P., Yin, M., & Lei, Q. (2019) · Cell Stress · doi:10.15698/cst2019.12.205 · Cited by 37
Take Advantage of Glutamine Anaplerosis, the Kernel of the Metabolic Rewiring in Malignant Gliomas
Martins, F., Gonçalves, L. G., Pojo, M., & Serpa, J. (2020) · Biomolecules · doi:10.3390/biom10101370 · Cited by 35
Dimethyl Fumarate Induces Metabolic Crisie to Suppress Pancreatic Carcinoma
Chen, K., Wu, S., Ye, S., Huang, H., Zhou, Y., Zhou, H., Wu, S., Mao, Y., Shangguan, F., Lan, L., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.617714 · Cited by 35
Chang, M. (2022) · Biomedicines · doi:10.3390/biomedicines10030692 · Cited by 38
Hickman, T. L., Choi, E., Whiteman, K. R., Muralidharan, S., Pai, T., Johnson, T., Parikh, A. B., Friedman, T., Gilbert, M., Shen, B., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266980 · Cited by 36
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer
Santis, M. C. D., Gozzelino, L., Margaria, J. P., Costamagna, A., Ratto, E., Gulluni, F., Gregorio, E. D., Mina, E., Lorito, N., Bacci, M., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-325117 · Cited by 34
Glutamine deprivation induces ferroptosis in pancreatic cancer cells
Xiao, Z., Deng, S., Liu, H., Wang, R., Liu, Y., Dai, Z., Gu, W., Ni, Q., Yu, X., Liu, C., et al. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023029 · Cited by 34
Warburg and Krebs and related effects in cancer
Unterlass, J. E., & Curtin, N. J. (2019) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2019.4 · Cited by 35
Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma
Shah, A., Ganguly, K., Rauth, S., Sheree, S. S., Khan, I., Ganti, A. K., Ponnusamy, M. P., Kumar, S., Jain, M., & Batra, S. K. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2024.101146 · Cited by 37
Jiang, X., Chang, H., & Zhou, Y. G. (2015) · Protein Expression and Purification · doi:10.1016/j.pep.2015.05.010 · Cited by 33
Brunelli, L., Caiola, E., Marabese, M., Broggini, M., & Pastorelli, R. (2016) · Scientific Reports · doi:10.1038/srep28398 · Cited by 33
Mechanistic Basis of Glutaminase Activation
Li, Y., Erickson, J. W., Stalnecker, C. A., Katt, W. P., Huang, Q., Cerione, R. A., & Ramachandran, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.720268 · Cited by 33
Molecular or Metabolic Reprograming: What Triggers Tumor Subtypes?
Eason, K., & Sadanandam, A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0141 · Cited by 33
Increased glutamine anabolism sensitizes non-small cell lung cancer to gefitinib treatment
Wang, L., Peng, W., Wu, T., Deng, P., & Zhao, Y. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0086-x · Cited by 34
The Role of Autophagy in Pancreatic Cancer—Recent Advances
New, M. I., & Tooze, S. A. (2019) · Biology · doi:10.3390/biology9010007 · Cited by 34
Supper, E., Rudat, S., Iyer, V., Droop, A., Wong, K., Spinella, J.-F., Thomas, P., Sauvageau, G., Adams, D. J., & Wong, C. C. (2021) · Nature Communications · doi:10.1038/s41467-021-22750-8 · Cited by 33
Autophagy Inhibition in BRAF-Driven Cancers
Foth, M., & McMahon, M. (2021) · Cancers · doi:10.3390/cancers13143498 · Cited by 33
Lu, H., Yin, H., Qu, L., Ma, X., Fu, R., & Fan, D. (2022) · Food & Function · doi:10.1039/d1fo03728e · Cited by 36
Liu, X., Qin, H., Li, Z., Lv, Y., Feng, S., Zhuang, W., Quan, X., Guo, C., Chen, C., & Zhang, H. (2022) · European Respiratory Journal · doi:10.1183/13993003.00062-2022 · Cited by 35
Regulation of tumor metabolism by post translational modifications on metabolic enzymes
Dessai, A. S., Kalhotra, P., Novickis, A. T., & Dasgupta, S. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00521-x · Cited by 38
A functional analysis of 180 cancer cell lines reveals conserved intrinsic metabolic programs
Cherkaoui, S., Durot, S., Bradley, J., Critchlow, S. E., Dubuis, S., Masiero, M. M., Wegmann, R., Snijder, B., Othman, A., Bendtsen, C., et al. (2022) · Molecular Systems Biology · doi:10.15252/msb.202211033 · Cited by 32
Li, X., Zhou, J., Wang, X., Li, C., Ma, Z., Wan, Q., & Fu, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1152312 · Cited by 38
Self-citationThe Ubiquitin–Proteasome System in Tumor Metabolism
Wang, J., Xiang, Y., Fan, M., Fang, S., & Hua, Q. (2023) · Cancers · doi:10.3390/cancers15082385 · Cited by 32
Targeting pancreatic cancer glutamine dependency confers vulnerability to GPX4-dependent ferroptosis
Shen, X., Chen, Y., Tang, Y., Lu, P., Liu, M., Mao, T., Weng, Y., Yu, F., Liu, Y., Tang, Y., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.101928 · Cited by 33
Wu, C., Xu, T.-H., Zhang, H.-Y., Hu, Y., Jiao, J., Qiu, K., Gu, J., Li, W.-Y., & Sun, L. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217913 · Cited by 32
Wang, A. S., Lodi, A., Rivera, L. B., Izquierdo-García, J. L., Firpo, M. A., Mulvihill, S. J., Tempero, M. A., Bergers, G., & Ronen, S. M. (2014) · NMR in Biomedicine · doi:10.1002/nbm.3198 · Cited by 32
Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction
Cetinbas, N. M., Daugaard, M., Mullen, A. R., Hajee, S., Rotblat, B., Lopez, A., Li, A.-P., DeBerardinis, R. J., & Sørensen, P. (2014) · Oncogene · doi:10.1038/onc.2014.316 · Cited by 32
Role of TFEB-driven autophagy regulation in pancreatic cancer treatment
Klein, K., Werner, K., Teske, C., Schenk, M., Giese, T., Weitz, J., & Welsch, T. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3505 · Cited by 34
Cogoi, S., Jakobsen, U., Pedersen, E. B., Vogel, S., & Xodo, L. E. (2016) · Scientific Reports · doi:10.1038/srep38468 · Cited by 32
Upadhyay, V. A., Brunner, A. M., & Fathi, A. T. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.03.003 · Cited by 33
MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG
Fets, L., Driscoll, P. C., Grimm, F., Jain, A., Nunes, P. M., Gounis, M., Doglioni, G., Papageorgiou, G., Ragan, T. J., Campos, S., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0136-y · Cited by 30
The role of metabolic adaptation to nutrient stress in pancreatic cancer
Derle, A., Santis, M. C. D., Gozzelino, L., Ratto, E., & Martini, M. (2018) · Cell Stress · doi:10.15698/cst2018.12.166 · Cited by 33
Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes
Meijer, T. W. H., Looijen-Salamon, M. G., Lok, J., van den Heuvel, M. M., Tops, B. B. J., Kaanders, J. H. A. M., Span, P. N., & Bussink, J. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.13226 · Cited by 32
Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease
Gromisch, C. M., Qadan, M., Machado, M. A., Liu, K., Colson, Y. L., & Grinstaff, M. W. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2731 · Cited by 32
Oxidative stress sensing and response in neural stem cell fate
Hwang, I., Tang, D., & Paik, J. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.03.043 · Cited by 33
Jain, P., Dvorkin‐Gheva, A., Mollen, E., Malbeteau, L., Xie, M. H., Jessa, F., Dhavarasa, P., Chung, S., Brown, K. R., Jang, G. H., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf7114 · Cited by 33
García‐Cañaveras, J. C., & Lahoz, A. (2021) · Cancers · doi:10.3390/cancers13133230 · Cited by 33
Heishima, K., Sugito, N., Soga, T., Nishikawa, M., Ito, Y., Honda, R. P., Kuranaga, Y., Sakai, H., Ito, R., Nakagawa, T., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci139933 · Cited by 32
Chisari, A. N., Golán, I., Campisano, S., Gélabert, C., Moustakas, A., Sancho, P., & Caja, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.723798 · Cited by 33
A “Weird” Mitochondrial Fatty Acid Oxidation as a Metabolic “Secret” of Cancer
Zhelev, Z., Aoki, I., Lazarova, D., Vlaykova, T. I., Higashi, T., & Bakalova, R. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2339584 · Cited by 34
Brashears, C. B., Prudner, B. C., Rathore, R., Caldwell, K. E., Dehner, C. A., Buchanan, J. L., Lange, S. E. S., Poulin, N., Sehn, J. K., Roszik, J., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0470 · Cited by 32
Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review)
Zuzčák, M., & Trnka, J. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5383 · Cited by 33
Yang, R., Zhang, X., Liu, J., Li, X., Zhou, D., & Luan, S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.039 · Cited by 32
Bark, J. M., Karpe, A. V., Doecke, J. D., Leo, P., Jeffree, R. L., Chua, B., Day, B. W., Beale, D. J., & Punyadeera, C. (2023) · Cancer Medicine · doi:10.1002/cam4.5857 · Cited by 31
Li, W., Chen, C., Zhao, X., Ye, H., Zhao, Y., Fu, Z., Pan, W., Zheng, S., Wei, L., Nong, T., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13202 · Cited by 35
Metadata
- Authors
- Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., Kang, Y., Fleming, J. B., Bardeesy, N., Asara, J. M., Haigis, M. C., DePinho, R. A., Cantley, L. C., & Kimmelman, A. C.
- Affiliations
- Dana-Farber Cancer Institute (US)
- Beth Israel Deaconess Medical Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Massachusetts General Hospital (US)
- Harvard University (US)
- Corresponding author
- Cantley, Lewis C.
- Kimmelman, Alec C.
- ORCID
- Venue
- Nature
- Published
- 2013-03-27
- Volume
- 496
- Issue
- 7443
- Pages
- 101-105
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3656466
- OpenAlex
- W2014988241
- Cited by
- 1,990
- References
- 27
- Citations by year
- 2026: 130 · 2025: 143 · 2024: 138 · 2023: 169 · 2022: 193 · 2021: 209 · 2020: 169 · 2019: 162 · 2018: 141 · 2017: 144 · 2016: 152 · 2015: 112 · 2014: 95 · 2013: 31
- FWCI
- 45.68
- Type
- journal article
- Language
- en
- Update notices
- erratum (2013-06-12)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Cancer Institute (T32CA009382, R01CA157490, P01CA120964, P01CA117969, P30CA006516)
- National Institute of General Medical Sciences (R01GM056203)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- pancreatic ductal adenocarcinoma, glutamine metabolism, KRAS, tumor metabolic reprogramming, oxaloacetate, NADPH/NADP+ ratio, redox homeostasis, glutamine deprivation, reactive oxygen species, glutathione, tumor growth
- MeSH terms
- Adenocarcinoma, Aspartate Aminotransferases, Citric Acid Cycle, Glutamate Dehydrogenase, Glutamine, Homeostasis, Humans, Ketoglutaric Acids, Oncogenes, Oxidation-Reduction, Pancreatic Neoplasms, Proto-Oncogene Proteins, Oncogene Protein p21(ras), Proto-Oncogene Proteins p21(ras), Reactive Oxygen Species, ras Proteins, Cell Line, Tumor, Cell Proliferation, Metabolic Networks and Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
